Zach Rothstein, the top AdvaMed lobbyist tasked with supporting the medical device industry’s interests in artificial intelligence and machine learning, talked to Medtech Insight about how FDA should regulate the fast-growing sector. He argues there likely won’t be a guidance on AI/ML for at least a year and even then the agency may need new congressional authorities for the guidance to come into effect.

No one likes unhappy surprises, especially when it comes to medical billing. In this week's Medtech Insight podcast, executive editor Shawn M. Schmitt and senior reporter Sue Darcey talk about so-called surprise billing by hospitals and other health-care facilities, how legislation wending its way through Congress is aiming to curb it, and why the medtech industry should care.

Medtech Insight articles addressing topics discussed in this episode:

• US Senate Sponsors Push Back Vote On Balanced Billing Legislation To Autumn

• New US State And Proposed Federal Laws Would Stop Specialists From Balance Billing

In this edition of Device Week, Medtech Insight's managing editor Marion Webb chats with deputy editor Reed Miller about recent earning reports from medtech giants Johnson & Johnson and Abbott.

Listen to the podcast via the player below:

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Johnson & Johnson Growth Led By Biosense Webster and Cerenovus

Abbott Delivers Strong Q2 Sales, Led By Spike In FreeStyle Libre Sales

Global Device Approvals Snapshot: 9-15 July 2019; MitraClip G4, Relievion, RAPID Imaging, ExAblate Neuro

Pink Sheet Regulatory Podcast Episode 9 by Citeline

Pink Sheet Regulatory Podcast Episode 8 by Citeline

Thinking of nominating yourself, a colleague, your company, or your team for an award this year but not sure where to start? We’ve prepared a podcast just for you with tips on putting together your entry as well as an overview of the CPhI Awards 2019.

In this edition of Device Week, Medtech Insight’s Marion Webb reviews her interview with Omron Healthcare CEO Ranndy Kellogg at the recent AdvaMed conference in San Francisco. Reed Miller discusses the latest cost-effectiveness study of Boston Scientific’s Watchman left-atrial appendage closure device.

For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2FWqEWl

Medtech Insight articles addressing topics discussed in this episode.

Expert Panel Discusses Impact Of Stricter US, EU Data Privacy Laws On Medtech Industry

http://bit.ly/2XydvJI

CES 2016: Consumer and Medical Devices Come Together in Digital Health

http://bit.ly/30fZeCG

Long-Term Analysis Shows Boston Scientific’s Watchman Device Saves Money

http://bit.ly/2Xr4KAD

Global Device Approvals, Weekly Snapshot: FDA Approves Bard’s Venovo Stent; Abbott’s MitraClip Gets Indication-Expansion; Boston Scientific’s Watchman FLX Earns CE Mark

http://bit.ly/2LaaVYb

Starts & Stops: Boston Scientific Completes Enrollment In Precision SCS, Watchman FLX, Lotus TAVR, Ranger II SFA Studies

http://bit.ly/2xxRRdo

It may often seem like Brexit is the only story in town in the UK, but within health care and medtech, a lot of system transformation and future planning for access to medtech innovation is underway, as this Medtech Insight podcast with Ashley Yeo and Amanda Maxwell underlines.

Pink Sheet Regulatory Podcast Episode 7 by Citeline

Pink Sheet Regulatory Podcast Episode 6 by Citeline